nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.192	0.248	CbGbCtD
Fosamprenavir—CYP3A4—Triamcinolone—ankylosing spondylitis	0.145	0.188	CbGbCtD
Fosamprenavir—CYP3A4—Betamethasone—ankylosing spondylitis	0.125	0.161	CbGbCtD
Fosamprenavir—CYP3A4—Prednisolone—ankylosing spondylitis	0.123	0.159	CbGbCtD
Fosamprenavir—CYP3A4—Prednisone—ankylosing spondylitis	0.116	0.15	CbGbCtD
Fosamprenavir—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0725	0.0938	CbGbCtD
Fosamprenavir—Buffalo hump—Prednisone—ankylosing spondylitis	0.009	0.0396	CcSEcCtD
Fosamprenavir—Lipohypertrophy—Prednisone—ankylosing spondylitis	0.00827	0.0364	CcSEcCtD
Fosamprenavir—Osteonecrosis—Prednisolone—ankylosing spondylitis	0.00667	0.0294	CcSEcCtD
Fosamprenavir—Osteonecrosis—Triamcinolone—ankylosing spondylitis	0.00613	0.027	CcSEcCtD
Fosamprenavir—Osteonecrosis—Methylprednisolone—ankylosing spondylitis	0.00612	0.0269	CcSEcCtD
Fosamprenavir—Opportunistic infection—Methylprednisolone—ankylosing spondylitis	0.00566	0.0249	CcSEcCtD
Fosamprenavir—Osteonecrosis—Dexamethasone—ankylosing spondylitis	0.00557	0.0245	CcSEcCtD
Fosamprenavir—Osteonecrosis—Betamethasone—ankylosing spondylitis	0.00557	0.0245	CcSEcCtD
Fosamprenavir—Opportunistic infection—Dexamethasone—ankylosing spondylitis	0.00515	0.0227	CcSEcCtD
Fosamprenavir—Opportunistic infection—Betamethasone—ankylosing spondylitis	0.00515	0.0227	CcSEcCtD
Fosamprenavir—Osteonecrosis—Prednisone—ankylosing spondylitis	0.00485	0.0213	CcSEcCtD
Fosamprenavir—Reaction gastrointestinal—Methotrexate—ankylosing spondylitis	0.00452	0.0199	CcSEcCtD
Fosamprenavir—Opportunistic infection—Prednisone—ankylosing spondylitis	0.00448	0.0197	CcSEcCtD
Fosamprenavir—Osteonecrosis—Methotrexate—ankylosing spondylitis	0.00405	0.0178	CcSEcCtD
Fosamprenavir—Opportunistic infection—Methotrexate—ankylosing spondylitis	0.00375	0.0165	CcSEcCtD
Fosamprenavir—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00314	0.0138	CcSEcCtD
Fosamprenavir—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.00276	0.0121	CcSEcCtD
Fosamprenavir—Inflammation—Methylprednisolone—ankylosing spondylitis	0.00235	0.0103	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.00207	0.00913	CcSEcCtD
Fosamprenavir—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.00191	0.0084	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.00191	0.00839	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.0019	0.00837	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.00173	0.00761	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.00173	0.00761	CcSEcCtD
Fosamprenavir—Inflammation—Methotrexate—ankylosing spondylitis	0.00156	0.00685	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.00151	0.00663	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00146	0.00642	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00137	0.00603	CcSEcCtD
Fosamprenavir—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00136	0.006	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00126	0.00554	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.00126	0.00554	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00126	0.00553	CcSEcCtD
Fosamprenavir—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00125	0.00552	CcSEcCtD
Fosamprenavir—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00125	0.00551	CcSEcCtD
Fosamprenavir—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00125	0.0055	CcSEcCtD
Fosamprenavir—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00125	0.00549	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00117	0.00516	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00117	0.00516	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00116	0.00509	CcSEcCtD
Fosamprenavir—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00115	0.00508	CcSEcCtD
Fosamprenavir—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00115	0.00506	CcSEcCtD
Fosamprenavir—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00115	0.00505	CcSEcCtD
Fosamprenavir—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00114	0.00504	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00114	0.00503	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00114	0.00503	CcSEcCtD
Fosamprenavir—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00114	0.005	CcSEcCtD
Fosamprenavir—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00114	0.005	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00113	0.00495	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00106	0.00468	CcSEcCtD
Fosamprenavir—Neutropenia—Prednisone—ankylosing spondylitis	0.00106	0.00466	CcSEcCtD
Fosamprenavir—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00105	0.0046	CcSEcCtD
Fosamprenavir—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00105	0.0046	CcSEcCtD
Fosamprenavir—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00104	0.00458	CcSEcCtD
Fosamprenavir—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00104	0.00458	CcSEcCtD
Fosamprenavir—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00103	0.00455	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00102	0.0045	CcSEcCtD
Fosamprenavir—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000997	0.00439	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000996	0.00438	CcSEcCtD
Fosamprenavir—Angioedema—Prednisolone—ankylosing spondylitis	0.000992	0.00437	CcSEcCtD
Fosamprenavir—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00099	0.00436	CcSEcCtD
Fosamprenavir—Angioedema—Triamcinolone—ankylosing spondylitis	0.000913	0.00402	CcSEcCtD
Fosamprenavir—Haemoglobin—Prednisone—ankylosing spondylitis	0.000911	0.00401	CcSEcCtD
Fosamprenavir—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000911	0.00401	CcSEcCtD
Fosamprenavir—Haemorrhage—Prednisone—ankylosing spondylitis	0.000907	0.00399	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000891	0.00392	CcSEcCtD
Fosamprenavir—Neutropenia—Methotrexate—ankylosing spondylitis	0.000885	0.0039	CcSEcCtD
Fosamprenavir—Myalgia—Triamcinolone—ankylosing spondylitis	0.00085	0.00374	CcSEcCtD
Fosamprenavir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000848	0.00373	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000843	0.00371	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000837	0.00368	CcSEcCtD
Fosamprenavir—Angioedema—Dexamethasone—ankylosing spondylitis	0.000828	0.00364	CcSEcCtD
Fosamprenavir—Angioedema—Betamethasone—ankylosing spondylitis	0.000828	0.00364	CcSEcCtD
Fosamprenavir—Immune system disorder—Prednisone—ankylosing spondylitis	0.000819	0.0036	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000798	0.00351	CcSEcCtD
Fosamprenavir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00079	0.00348	CcSEcCtD
Fosamprenavir—Malnutrition—Prednisone—ankylosing spondylitis	0.000789	0.00347	CcSEcCtD
Fosamprenavir—Myalgia—Betamethasone—ankylosing spondylitis	0.000772	0.0034	CcSEcCtD
Fosamprenavir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000772	0.0034	CcSEcCtD
Fosamprenavir—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000762	0.00335	CcSEcCtD
Fosamprenavir—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000758	0.00333	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000748	0.00329	CcSEcCtD
Fosamprenavir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000743	0.00327	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000743	0.00327	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000741	0.00326	CcSEcCtD
Fosamprenavir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000725	0.00319	CcSEcCtD
Fosamprenavir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000725	0.00319	CcSEcCtD
Fosamprenavir—Angioedema—Prednisone—ankylosing spondylitis	0.000721	0.00317	CcSEcCtD
Fosamprenavir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000716	0.00315	CcSEcCtD
Fosamprenavir—Anorexia—Dexamethasone—ankylosing spondylitis	0.000705	0.0031	CcSEcCtD
Fosamprenavir—Anorexia—Betamethasone—ankylosing spondylitis	0.000705	0.0031	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000703	0.00309	CcSEcCtD
Fosamprenavir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000703	0.00309	CcSEcCtD
Fosamprenavir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000701	0.00309	CcSEcCtD
Fosamprenavir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000684	0.00301	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000674	0.00297	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000674	0.00297	CcSEcCtD
Fosamprenavir—Myalgia—Prednisone—ankylosing spondylitis	0.000672	0.00296	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000667	0.00294	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000665	0.00293	CcSEcCtD
Fosamprenavir—Malnutrition—Methotrexate—ankylosing spondylitis	0.00066	0.0029	CcSEcCtD
Fosamprenavir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000653	0.00287	CcSEcCtD
Fosamprenavir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000644	0.00284	CcSEcCtD
Fosamprenavir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000643	0.00283	CcSEcCtD
Fosamprenavir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000643	0.00283	CcSEcCtD
Fosamprenavir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000643	0.00283	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000639	0.00281	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000639	0.00281	CcSEcCtD
Fosamprenavir—Fatigue—Dexamethasone—ankylosing spondylitis	0.000638	0.00281	CcSEcCtD
Fosamprenavir—Fatigue—Betamethasone—ankylosing spondylitis	0.000638	0.00281	CcSEcCtD
Fosamprenavir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000632	0.00278	CcSEcCtD
Fosamprenavir—Skin disorder—Prednisone—ankylosing spondylitis	0.000626	0.00275	CcSEcCtD
Fosamprenavir—Anorexia—Prednisone—ankylosing spondylitis	0.000614	0.0027	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000605	0.00266	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000605	0.00266	CcSEcCtD
Fosamprenavir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000601	0.00264	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000599	0.00264	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000587	0.00258	CcSEcCtD
Fosamprenavir—Dizziness—Prednisolone—ankylosing spondylitis	0.000586	0.00258	CcSEcCtD
Fosamprenavir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000585	0.00257	CcSEcCtD
Fosamprenavir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000585	0.00257	CcSEcCtD
Fosamprenavir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000585	0.00257	CcSEcCtD
Fosamprenavir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000585	0.00257	CcSEcCtD
Fosamprenavir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000585	0.00257	CcSEcCtD
Fosamprenavir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000584	0.00257	CcSEcCtD
Fosamprenavir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000577	0.00254	CcSEcCtD
Fosamprenavir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000575	0.00253	CcSEcCtD
Fosamprenavir—Myalgia—Methotrexate—ankylosing spondylitis	0.000562	0.00247	CcSEcCtD
Fosamprenavir—Decreased appetite—Prednisone—ankylosing spondylitis	0.00056	0.00246	CcSEcCtD
Fosamprenavir—Rash—Prednisolone—ankylosing spondylitis	0.000559	0.00246	CcSEcCtD
Fosamprenavir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000558	0.00246	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000558	0.00245	CcSEcCtD
Fosamprenavir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000557	0.00245	CcSEcCtD
Fosamprenavir—Fatigue—Prednisone—ankylosing spondylitis	0.000555	0.00244	CcSEcCtD
Fosamprenavir—Headache—Prednisolone—ankylosing spondylitis	0.000555	0.00244	CcSEcCtD
Fosamprenavir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000539	0.00237	CcSEcCtD
Fosamprenavir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000538	0.00237	CcSEcCtD
Fosamprenavir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000531	0.00234	CcSEcCtD
Fosamprenavir—Asthenia—Betamethasone—ankylosing spondylitis	0.000531	0.00234	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000528	0.00232	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000527	0.00232	CcSEcCtD
Fosamprenavir—Nausea—Prednisolone—ankylosing spondylitis	0.000527	0.00232	CcSEcCtD
Fosamprenavir—Pruritus—Betamethasone—ankylosing spondylitis	0.000523	0.0023	CcSEcCtD
Fosamprenavir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000523	0.0023	CcSEcCtD
Fosamprenavir—Skin disorder—Methotrexate—ankylosing spondylitis	0.000523	0.0023	CcSEcCtD
Fosamprenavir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000518	0.00228	CcSEcCtD
Fosamprenavir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000517	0.00228	CcSEcCtD
Fosamprenavir—Rash—Triamcinolone—ankylosing spondylitis	0.000514	0.00226	CcSEcCtD
Fosamprenavir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000514	0.00226	CcSEcCtD
Fosamprenavir—Anorexia—Methotrexate—ankylosing spondylitis	0.000513	0.00226	CcSEcCtD
Fosamprenavir—Rash—Methylprednisolone—ankylosing spondylitis	0.000513	0.00226	CcSEcCtD
Fosamprenavir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000512	0.00225	CcSEcCtD
Fosamprenavir—Headache—Triamcinolone—ankylosing spondylitis	0.000511	0.00225	CcSEcCtD
Fosamprenavir—Headache—Methylprednisolone—ankylosing spondylitis	0.00051	0.00224	CcSEcCtD
Fosamprenavir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000509	0.00224	CcSEcCtD
Fosamprenavir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000509	0.00224	CcSEcCtD
Fosamprenavir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000506	0.00223	CcSEcCtD
Fosamprenavir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000506	0.00223	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00049	0.00216	CcSEcCtD
Fosamprenavir—Dizziness—Dexamethasone—ankylosing spondylitis	0.000489	0.00215	CcSEcCtD
Fosamprenavir—Dizziness—Betamethasone—ankylosing spondylitis	0.000489	0.00215	CcSEcCtD
Fosamprenavir—Nausea—Triamcinolone—ankylosing spondylitis	0.000484	0.00213	CcSEcCtD
Fosamprenavir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000483	0.00213	CcSEcCtD
Fosamprenavir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000475	0.00209	CcSEcCtD
Fosamprenavir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00047	0.00207	CcSEcCtD
Fosamprenavir—Vomiting—Betamethasone—ankylosing spondylitis	0.00047	0.00207	CcSEcCtD
Fosamprenavir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000468	0.00206	CcSEcCtD
Fosamprenavir—Rash—Betamethasone—ankylosing spondylitis	0.000466	0.00205	CcSEcCtD
Fosamprenavir—Rash—Dexamethasone—ankylosing spondylitis	0.000466	0.00205	CcSEcCtD
Fosamprenavir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000466	0.00205	CcSEcCtD
Fosamprenavir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000466	0.00205	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000465	0.00205	CcSEcCtD
Fosamprenavir—Fatigue—Methotrexate—ankylosing spondylitis	0.000464	0.00204	CcSEcCtD
Fosamprenavir—Headache—Dexamethasone—ankylosing spondylitis	0.000463	0.00204	CcSEcCtD
Fosamprenavir—Headache—Betamethasone—ankylosing spondylitis	0.000463	0.00204	CcSEcCtD
Fosamprenavir—Asthenia—Prednisone—ankylosing spondylitis	0.000462	0.00203	CcSEcCtD
Fosamprenavir—Pruritus—Prednisone—ankylosing spondylitis	0.000456	0.00201	CcSEcCtD
Fosamprenavir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000441	0.00194	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00044	0.00194	CcSEcCtD
Fosamprenavir—Nausea—Betamethasone—ankylosing spondylitis	0.000439	0.00193	CcSEcCtD
Fosamprenavir—Nausea—Dexamethasone—ankylosing spondylitis	0.000439	0.00193	CcSEcCtD
Fosamprenavir—Dizziness—Prednisone—ankylosing spondylitis	0.000426	0.00187	CcSEcCtD
Fosamprenavir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000426	0.00187	CcSEcCtD
Fosamprenavir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000426	0.00187	CcSEcCtD
Fosamprenavir—Vomiting—Prednisone—ankylosing spondylitis	0.00041	0.0018	CcSEcCtD
Fosamprenavir—Rash—Prednisone—ankylosing spondylitis	0.000406	0.00179	CcSEcCtD
Fosamprenavir—Dermatitis—Prednisone—ankylosing spondylitis	0.000406	0.00179	CcSEcCtD
Fosamprenavir—Headache—Prednisone—ankylosing spondylitis	0.000404	0.00178	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000397	0.00175	CcSEcCtD
Fosamprenavir—Asthenia—Methotrexate—ankylosing spondylitis	0.000386	0.0017	CcSEcCtD
Fosamprenavir—Nausea—Prednisone—ankylosing spondylitis	0.000383	0.00168	CcSEcCtD
Fosamprenavir—Pruritus—Methotrexate—ankylosing spondylitis	0.000381	0.00168	CcSEcCtD
Fosamprenavir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000368	0.00162	CcSEcCtD
Fosamprenavir—Dizziness—Methotrexate—ankylosing spondylitis	0.000356	0.00157	CcSEcCtD
Fosamprenavir—Vomiting—Methotrexate—ankylosing spondylitis	0.000342	0.00151	CcSEcCtD
Fosamprenavir—Rash—Methotrexate—ankylosing spondylitis	0.000339	0.00149	CcSEcCtD
Fosamprenavir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000339	0.00149	CcSEcCtD
Fosamprenavir—Headache—Methotrexate—ankylosing spondylitis	0.000337	0.00148	CcSEcCtD
Fosamprenavir—Nausea—Methotrexate—ankylosing spondylitis	0.00032	0.00141	CcSEcCtD
